A Study of Guselkumab Subcutaneous Therapy in Participants With Moderately to Severely Active Crohn's Disease
Clinical trial NCT05197049 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05197049
- Sponsor
- Janssen Research & Development, LLC
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-01-19
- Primary completion
- 2023-07-04
- Enrollment
- 350
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.